Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Botulinum toxin A: First-line therapy for idiopathic detrusor overactivity.

Literature DB >> 21672486

Botulinum toxin A: First-line therapy for idiopathic detrusor overactivity.

Stephen S Steele¹.

Abstract

Year: 2011 PMID： 21672486 PMCID： PMC3114034 DOI： 10.5489/cuaj.11045

Source DB: PubMed Journal: Can Urol Assoc J ISSN： 1911-6470 Impact factor: 1.862

× No keyword cloud information.

23 in total

Review 1. Repeat botulinum toxin-A injections for treatment of adult detrusor overactivity.

Authors: Christopher Dowson; Mohammad Shamim Khan; Prokar Dasgupta; Arun Sahai
Journal: Nat Rev Urol Date: 2010-12 Impact factor: 14.432

2. Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups.

Authors: A L Komaroff; L R Fagioli; T H Doolittle; B Gandek; M A Gleit; R T Guerriero; R J Kornish; N C Ware; J E Ware; D W Bates
Journal: Am J Med Date: 1996-09 Impact factor: 4.965

3. Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis.

Authors: Rui Pinto; Tiago Lopes; Bárbara Frias; André Silva; João Alturas Silva; Carlos Martins Silva; Célia Cruz; Francisco Cruz; Paulo Dinis
Journal: Eur Urol Date: 2010-03-06 Impact factor: 20.096

4. Urge incontinence. Quality of life and patients' valuation of symptom reduction.

Authors: R M O'Conor; M Johannesson; S L Hass; G Kobelt-Nguyen
Journal: Pharmacoeconomics Date: 1998-11 Impact factor: 4.981

Review 5. Outcomes of intravesical botulinum toxin for idiopathic overactive bladder symptoms: a systematic review of the literature.

Authors: Jennifer T Anger; Aviva Weinberg; Marika J Suttorp; Mark S Litwin; Paul G Shekelle
Journal: J Urol Date: 2010-04-18 Impact factor: 7.450

6. Botulinum toxin a has antinociceptive effects in treating interstitial cystitis.

Authors: Christopher P Smith; Piotr Radziszewski; Andrzej Borkowski; George T Somogyi; Timothy B Boone; Michael B Chancellor
Journal: Urology Date: 2004-11 Impact factor: 2.649

7. Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial.

Authors: Roger Dmochowski; Christopher Chapple; Victor W Nitti; Michael Chancellor; Karel Everaert; Catherine Thompson; Grace Daniell; Jihao Zhou; Cornelia Haag-Molkenteller
Journal: J Urol Date: 2010-10-16 Impact factor: 7.450

8. Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial.

Authors: Arun Sahai; Christopher Dowson; Mohammad S Khan; Prokar Dasgupta
Journal: BJU Int Date: 2009-04-15 Impact factor: 5.588

9. Clean intermittent self-catheterization after botulinum neurotoxin type A injections: short-term effect on quality of life.

Authors: Thomas M Kessler; Shahid Khan; Jalesh Panicker; Alexander Roosen; Sohier Elneil; Clare J Fowler
Journal: Obstet Gynecol Date: 2009-05 Impact factor: 7.661